When managing acute vascular compromise secondary to hyaluronic acid filler, what initial hyaluronidase dosing protocol do you employ, and do you find clinical value in traditional adjuncts like aspirin, nitroglycerin paste, or hyperbaric oxygen?

In your acute management protocol for hyaluronic acid filler-induced vascular compromise, do you routinely use aspirin, topical nitroglycerin paste, or oral vasodilators alongside hyaluronidase? Please select all that apply.

• Aspirin
• Topical nitroglycerin paste
• PO vasodilator (eg. sildenafil)
• Hyperbaric oxygen
• None of the above
• Other